FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely phthisiology and infectious diseases, and may be used for detection of immune reconstitution inflammatory disease in the patients suffering drug-resistant tuberculosis and HIV infection. That is ensured by clinical assessment of the patient's state with underlying high-active antiretroviral therapy (HAART). If observing general loss of condition, temperature rise, progression of inflammatory process in the involved organs, prednisolone 0.5 mg/kg therapy is prescribed once a day for 10-12 days. The therapeutic course of prednisolone is followed by another clinical assessment, and if observing normalised temperature, regression of inflammatory process, general amelioration, the presence of immune reconstitution disease is stated.
EFFECT: use of the given method enables higher accuracy of detection of immune reconstitution disease in the patients with drug-resistant tuberculosis and HIV infection with underlying HAART.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS OR HIV-INFECTION | 2011 |
|
RU2482848C1 |
METHOD FOR DETERMINING INFLAMMATORY SYNDROME OF IMMUNE RECONSTRUCTION IN PATIENTS WITH TUBERCULOSIS AND HIV INFECTION AGAINST THE BACKGROUND OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) | 2020 |
|
RU2745026C1 |
METHOD OF PREDICTING EFFICIENCY OF ANTIRETROVIRAL THERAPY IN CASE IN HIV-INFECTION | 2009 |
|
RU2414858C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-INFECTION PATIENTS | 2008 |
|
RU2383342C1 |
METHOD FOR EVALUATING RISK OF DEVELOPING CENTRAL NERVOUS SYSTEM TUBERCULOSIS IN PATIENTS SUFFERING HIV-ASSOCIATED RESPIRATORY TUBERCULOSIS | 2011 |
|
RU2487355C1 |
METHOD FOR PREDICTING THE SURVIVAL PERIOD OF PATIENTS WITH THE CLINICAL COURSE OF HIV AND TUBERCULOSIS COINFECTION, ACCOMPANIED BY MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2021 |
|
RU2764830C1 |
METHOD OF ASSESSMENT THE SEVERITY OF A PATIENT'S CONDITION AT HIV INFECTION | 2017 |
|
RU2670652C2 |
METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION | 2020 |
|
RU2750715C1 |
METHOD OF TREATING CHRONIC HEPATITIS IN HIV POSITIVE PATIENTS | 2009 |
|
RU2412699C1 |
TREATMENT METHOD OF PULMONARY TUBERCULOISIS WITH HIV-INFECTED PATIENTS | 2008 |
|
RU2368372C1 |
Authors
Dates
2012-12-10—Published
2011-07-27—Filed